#astrazeneca

[ follow ]
US politics
fromBusiness Matters
1 week ago

AstraZeneca to invest $50bn in US amid pressure from Trump administration

AstraZeneca plans to invest $50 billion in the U.S. by 2030, pressured by the Trump administration.
#pharmaceuticals
more#pharmaceuticals
#investment
fromFortune
1 week ago
Healthcare

AstraZeneca CEO Pascal Soriot on why he's building in the U.S.: 'Europe is losing ground'

fromFortune
1 week ago
Healthcare

AstraZeneca CEO Pascal Soriot on why he's building in the U.S.: 'Europe is losing ground'

more#investment
fromwww.theguardian.com
1 week ago

AstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats

AstraZeneca's $50bn investment aims to establish a new drug manufacturing facility in Virginia and expand research and development across various US states, highlighting a significant commitment to US operations in response to looming tariffs on foreign pharmaceuticals.
US politics
fromLondon Business News | Londonlovesbusiness.com
3 weeks ago

Reeves hit with another blow as AstraZeneca considering leaving the UK

Sir Pascal Soriot has repeatedly highlighted the need for Europe to enhance its incentives for new medicines, warning that jobs could relocate to the US if these conditions remain unchanged.
UK news
fromwww.theguardian.com
4 weeks ago

If AstraZeneca goes to the US it will be a major blow for London and Labour

Pascal Soriot is considering moving AstraZeneca's corporate base to the US, impacting the company's UK presence and raising concerns in the scientific community.
fromwww.theguardian.com
4 weeks ago

AstraZeneca boss wants to shift stock market listing to US'

AstraZeneca's CEO plans to relocate the company's stock market listing from the UK to the US.
fromwww.theguardian.com
4 months ago

AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing

AstraZeneca's $2.5 billion investment in Beijing aims to strengthen its research capabilities and move beyond recent controversies by fostering collaborations with local biotech companies.
European startups
UK news
fromBusiness Matters
4 months ago

Astrazeneca scrapped 450m vaccine plant after government missed funding deadline

AstraZeneca canceled a £450 million investment due to the UK government missing a key funding deadline, stalling the project's progress.
UK politics
fromwww.theguardian.com
5 months ago

AstraZeneca's 450m Speke U-turn looks terrible for a pro-growth government | Nils Pratley

AstraZeneca's £450m investment in Liverpool signifies a renewed confidence in the UK's life sciences sector.
fromInsideHook
10 months ago

An FDA Ruling Could Make Nasal Vaccines Much More Widespread

The FDA has approved the FluMist nasal vaccine for home use, enhancing convenience and accessibility for flu vaccinations.
[ Load more ]